Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes

Diabetologia

Volumn 43, Issue 8, 2000, Pages 974-977

  Chowienczyk, P J ^a   Brett, S E ^a   Gopaul, N K ^b   Meeking, D ^a   Marchetti, M ^c   Russell Jones, D L ^a   Anggard E E ^b   Ritter, J M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Biomedica Foscama   (Italy)

Author keywords

Acetylcholine; Endothelium; Free radicals; Lipid peroxidation; Nitric oxide; Prostaglandins

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLCHOLINE; ANTIOXIDANT; ARACHIDONIC ACID; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; RAXOFELAST;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANTIOXIDANTS; BENZOFURANS; BIOLOGICAL MARKERS; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 2; DINOPROST; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDATIVE STRESS; REFERENCE VALUES; VASODILATION; VITAMIN E;

EID: 0033842518     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051478     Document Type: Article

References (10)

1. Oxidative stress and lipids in diabetes: A role in endothelium vasodilator dysfunction?
2. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin dependent diabetes mellitus
3. Raxofelast (IRFI 016): A new hydrophilic vitamin E-like antioxidant agent
4. The isoprostanes: Current knowledge and directions for future research
5. Plasma 8-epi-PGF(2α) levels are elevated in individuals with non-insulin dependent diabetes mellitus
6. Antioxidant status and lipid peroxidation in Type II diabetes mellitus with and without complications
7. 2-induced derangements of pulmonary artery endothelial cell barrier function
8. Nitric oxide: Physiology, pathophysiology, and pharmacology
9. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue
10. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation